Teleflex Stock News

Teleflex Incorporated (NYSE:TFX)s share price hit a new 52-week low during trading on Friday . The stock traded as low as $325.34 and last traded at $325.59, with a volume of 1831 shares changing hands. The stock had previously closed at $329.99. TFX has been the subject of several recent research reports. Zacks Investment Research []

Wall Street analysts expect Teleflex Incorporated (NYSE:TFX) to post earnings per share of $3.54 for the current quarter, according to Zacks. Ten analysts have issued estimates for Teleflexs earnings, with the highest EPS estimate coming in at $3.63 and the lowest estimate coming in at $3.49. Teleflex posted earnings of $3.25 per share in the []

Las Vegas, USA, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Urinary Catheters Market is Anticipated to Grow at a Tremendous CAGR of 6.63% and is Expected to Expand to USD 4.55 Billion by 2026, Asserts DelveInsight As per DelveInsight Analysis for Urinary Catheters market, the escalating prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia, and urinary strictures, among others, and growing surgical procedures worldwide are some of the key factors, which are anticipated to increase the overall demand of Urinary Catheters, thereby augmenting the growth of Urinary Catheters market. DelveInsight''s Urinary Catheters Market Insights and Forecast report provides the current and forecast Urinary Catheters, upcoming innovation in the devices, individual market shares of the devices, challenges, drivers and barriers, market trends, and key competitors in the Urinary Catheters. Some of the essential takeaways from the Urinary Catheters Market report: As per an analysis by DelveInsight, North America is expected to dominate the overall Urinary Catheters Market during the forecast period.

Global Nephrostomy Guidewires Market Overview: The universal Nephrostomy Guidewires Market report gives us an in-depth overview of the research trends for the financial year 2021. The base year for calculation in the report is taken as 2020 while the historic year

WAYNE, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced it was named a winner in the MedReps.com Best Places to Work in Medical Sales 2022 survey, earning the Number 1 spot for large companies and making this the fifth consecutive year the company has been on the list.

WAYNE, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Thomas Powell, Executive Vice President and CFO, Teleflex Incorporated (NYSE: TFX), is pleased to participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. From November 22 nd to December 2 nd , 2021, registered attendees can access a pre-recorded presentation via the Piper Sandler conference site. Teleflex will be participating in 1x1 meetings on December 2, 2021. Investor meetings can be requested exclusively via Piper Sandler.

Related Stocks: V , XOM , DVN , RY , FB , PBR , CRM , ALC , ZI , MA , MPWR , SNAP , BABA , HUM , BAC , LRCX , VALE , NTES , AEO , LEVI , X , NUE , TFX ,

This Respiratory Therapy Equipment market report depicts industrial analysis, growth factors, driving factors and recent market trends, which greatly benefit to the newly entering key players in the industry. This market report is very important for them as it covers

Related Stocks: ICLR , TMO , GLOB , HTGC , OMCL , TECH , MRVI , DOCS , MRNA , AVTR , STLD , CPRI , BRK.B , SMG , TKR , PNR , TFX , GM ,

Bouvel Investment Partners LLC grew its position in Teleflex Incorporated (NYSE:TFX) by 2.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,992 shares of the medical technology company’s stock after acquiring an additional 155 shares during the period. Bouvel Investment Partners LLC’s […]

Canada Varicose Vein Treatment Devices Market: Overview As per the study published in NCBI or National Centre for Biotechnology Information, over 3.7 million people in Canada are living with varicose veins. This has considerably heightened the need for effective and enhanced

Investors are optimistic about Teleflex (TFX) owing to better-than-anticipated results in the third quarter and strength in the Vascular business.

Global Mucosal Atomization Devices Industry: with growing significant CAGR during Forecast 2020-2027 Latest Research Report on Mucosal Atomization Devices Market which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), and Consumption Analysis Understand the influence of COVID-19 on the Mucosal Atomization Devices Market with our analysts monitoring the situation across the globe. []

Teleflex Incorporated (NYSE:TFX) VP Cameron P. Hicks sold 3,600 shares of the stock in a transaction dated Wednesday, November 10th. The shares were sold at an average price of $350.00, for a total value of $1,260,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC []

Teleflex's (TFX) CEO Liam Kelly on Q3 2021 Results - Earnings Call Transcript